Best GLP-1 Weight Loss Medications Compared in 2026

If you're comparing semaglutide, tirzepatide, and liraglutide for weight loss in 2026, the right choice depends on how much weight you want to lose, how often you want to inject, and how your body handles each medication class — not which one trends on social media. This guide breaks down the GLP-1 and dual-agonist options available today so you walk into a consultation with real questions instead of guesswork.

Why this matters

GLP-1 medications work by slowing digestion and reducing appetite signals, but they are not interchangeable. Dosing schedules differ, side effect profiles differ, and the amount of weight loss reported in clinical trials differs by a meaningful margin between drugs.

At Skindale Medspa, weight loss decisions go through the Skindale FIT medical weight loss program, where a consultation looks at your health history before any medication gets discussed. This comparison is a starting point for that conversation, not a substitute for it.

What makes the best GLP-1 medication

• Average weight loss in published clinical trials — the clearest apples-to-apples comparison across drugs
• Dosing frequency — weekly injection versus daily injection changes how easy a medication is to stick with
• FDA approval status — brand-name weight loss indications versus off-label or compounded use
• Side effect profile — nausea, GI symptoms, and how they're managed through dose titration
• Medical supervision required — how closely dosing needs to be monitored and adjusted
• Sourcing — brand-name pharmacy fill versus compounded formulation

GLP-1 medications at a glance

Medication	Best for	Standout feature	Key limitation
Semaglutide (Wegovy)	Most patients starting GLP-1 treatment	FDA-approved specifically for weight management	GI side effects during dose escalation
Tirzepatide (Zepbound)	Patients targeting higher average weight loss	Dual GIP/GLP-1 mechanism	Newer to market, less long-term data
Semaglutide (Ozempic)	Patients managing type 2 diabetes who also want weight loss	Same active ingredient as Wegovy, different approved use	Off-label for weight loss alone
Liraglutide (Saxenda)	Patients who prefer daily dosing	Longest track record among GLP-1 options	Daily injections, generally lower average weight loss
Compounded semaglutide/tirzepatide	Patients needing broader access under medical supervision	Formulated to match individual dosing needs	Requires a licensed provider and verified pharmacy

1. Semaglutide (Wegovy): best GLP-1 medication for most first-time patients

Wegovy is the semaglutide formulation FDA-approved specifically for chronic weight management, not diabetes. It's a once-weekly injection, and the STEP 1 trial reported an average of roughly 15% body weight loss over 68 weeks at the highest studied dose.

Wegovy pros:

• Once-weekly dosing schedule
• FDA-approved specifically for weight loss
• Years of real-world prescribing behind it

Wegovy cons:

• Nausea and GI symptoms common early in dose titration
• Weight regain is common after stopping without a maintenance plan

Best for: patients without diabetes who want an established, once-weekly starting option. Verdict: Strong first option to discuss with a provider.

2. Tirzepatide (Zepbound): best GLP-1 medication for higher average weight loss

Zepbound is tirzepatide's FDA-approved weight loss formulation. It acts on both GIP and GLP-1 receptors, and the SURMOUNT-1 trial reported average weight loss near 21% at the highest dose over 72 weeks — higher than the semaglutide trial averages.

Zepbound pros:

• Highest average weight loss among FDA-approved options in trial data
• Once-weekly injection

Zepbound cons:

• Less long-term real-world data than semaglutide
• Same GI side effect pattern during titration

Best for: patients who have discussed higher weight-loss targets with their provider and tolerated GLP-1 therapy before. Verdict: Worth asking about if semaglutide alone hasn't met your goals.

3. Semaglutide (Ozempic): best GLP-1 medication for patients already managing type 2 diabetes

Ozempic and Wegovy share the same active ingredient, semaglutide, but Ozempic is FDA-approved for type 2 diabetes management. Some patients already prescribed Ozempic for blood sugar control see weight loss as a secondary effect.

Ozempic pros:

• Well-established for blood sugar management
• Same weekly dosing convenience as Wegovy

Ozempic cons:

• Not FDA-approved specifically for weight loss
• Using it off-label for weight loss alone needs a direct conversation with your provider

Best for: patients managing diabetes whose provider is already coordinating that treatment. Verdict: Discuss with your prescribing provider rather than requesting it for weight loss alone.

4. Liraglutide (Saxenda): best GLP-1 medication for daily-dose preference

Saxenda was one of the earlier GLP-1 medications approved for chronic weight management and requires a daily injection rather than weekly. It has a longer track record than tirzepatide but generally shows lower average weight loss in trials than semaglutide or tirzepatide.

Saxenda pros:

• Long-established safety record
• Daily dosing gives more flexibility to adjust or pause

Saxenda cons:

• Daily injections are a bigger commitment than weekly options
• Average weight loss trends lower than newer GLP-1 medications

Best for: patients who want daily-dose flexibility or whose provider recommends starting more conservatively. Verdict: Reasonable alternative if weekly dosing doesn't fit your routine.

5. Compounded semaglutide/tirzepatide: best GLP-1 option for widening access under supervision

Compounded versions of semaglutide and tirzepatide are formulated by licensed pharmacies to match individual dosing needs, often used when brand-name supply or coverage is limited. Compounded medications still require prescribing and monitoring by a licensed provider.

Compounded GLP-1 pros:

• Can widen access when brand-name options are constrained
• Dosing can be adjusted more precisely under supervision

Compounded GLP-1 cons:

• Quality depends entirely on the sourcing pharmacy
• Not the same as an FDA-approved product, even with the same active ingredient

Best for: patients working with a provider who can verify the compounding pharmacy and monitor dosing closely. Verdict: Only through a provider you trust to vet the source.

How we ranked

Each medication above is measured against the criteria listed earlier: published trial weight-loss averages, dosing frequency, FDA approval status, and how much medical oversight the option requires. Nothing here is ranked by marketing claims — semaglutide and tirzepatide's trial numbers come from their respective published studies, and the rest of the comparison sits on approval status and dosing schedule, which don't change based on who's selling the medication.

Which GLP-1 medication should you choose?

For most patients without diabetes starting GLP-1 treatment in 2026, Wegovy remains a reasonable default given its approval status and dosing convenience. Patients targeting a higher percentage of weight loss, or who haven't hit their goals on semaglutide, should ask specifically about Zepbound. If weekly injections aren't a fit, Saxenda's daily dose is worth a conversation.

None of this replaces a real evaluation. The team at Skindale Medspa walks through your health history, current medications, and goals before recommending anything — that conversation is what actually determines which option fits, not a ranked list on a page.

FAQ

One last thing

Published research on stopping GLP-1 medications, including the STEP 4 withdrawal data, shows that weight regain is common once the medication stops without a maintenance plan in place. Whichever GLP-1 medication you and your provider land on in 2026, the plan for what happens after the weight-loss phase matters as much as the medication itself.

Related guides

• Best dermal filler brands compared
• Best vitamin injections for energy compared
• Best wrinkle relaxer brands compared